CLINICAL TRIALS
Anemia Treatment in Kidney Disease
Study summary: We are conducting several trials comparing standard treatment of anemia with a new investigational oral medication.
Principal investigator: Matthew K. Abramowitz, MD
Major criteria to enter the study: Adults with stage 3, 4 or 5 chronic kidney disease (kidney function less than 60%) who have been diagnosed with anemia. People who have never been treated for anemia as well as those already receiving treatment may be eligible.
Patient referrals
At Montefiore Einstein Nephrology, we know that providing patients with the best possible care includes teamwork and trust. We work closely with our valued referring physicians to ensure open communication and reliable expertise.
Contact us
Michael J. Ross, MD
Chief, Division of Nephrology
michael.ross@einsteinmed.org